Trinity Biotech (TRIB) Consolidated Net Income (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly Consolidated Net Income of -$573000.0 for Q4 2024, down 19000.0% year-on-year from N/an in Q1 2024, and up 88.13% on a QoQ basis from -$4.8 million in Q3 2024.
Trinity Biotech (TRIB) Consolidated Net Income (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported Consolidated Net Income for 16 consecutive years, with -$573000.0 the latest figure, recorded in Q4 2024.
- Quarterly Consolidated Net Income fell 19000.0% year-over-year to -$573000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$5.4 million (up 65.38% YoY) and the FY2025 annual result came in at -$37.4 million, down 6422.86% from the prior year.
- Consolidated Net Income rose to -$573000.0 in Q4 2024 per TRIB's latest filing, from -$4.8 million in the prior quarter.
- Over the last five years, Consolidated Net Income for TRIB reached as high as $12.4 million in Q2 2023 and fell as low as -$15.0 million in Q4 2020.
- A 5-year average of $139250.0 and a median of $374000.0 in 2022 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2022 — Consolidated Net Income soared 3696.55% — and 2024, when it sank 482800.0%.
- Year by year, Consolidated Net Income stood at -$15.0 million in 2020, then jumped by 99.83% to -$25000.0 in 2021, then soared by 1444.0% to $336000.0 in 2022, then plunged by 100.89% to -$3000.0 in 2023, then tumbled by 19000.0% to -$573000.0 in 2024.
- According to Business Quant data, Consolidated Net Income over the past three periods registered -$573000.0, -$4.8 million, and -$7.0 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -573,000.00 |
| Sep 30, 2024 | -4.83 Mn |
| Jun 30, 2024 | -7.02 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | 12.36 Mn |
| Mar 31, 2023 | 496,000.00 |
| Dec 31, 2022 | 336,000.00 |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 412,000.00 |
| Mar 31, 2022 | 791,000.00 |
| Dec 31, 2021 | -25,000.00 |
| Sep 30, 2021 | -29,000.00 |
| Jun 30, 2021 | 527,000.00 |
| Mar 31, 2021 | 4.39 Mn |
| Dec 31, 2020 | -15.01 Mn |
| Sep 30, 2020 | 8.26 Mn |
| Jun 30, 2020 | 1.76 Mn |
| Mar 31, 2020 | 3.09 Mn |